Table 5 |
||||
|
Determinants of rapid radiographic progression of RA for patients with early RA who received DMARDs (multivariate analysis). |
||||
|
Estimate |
Standard Error |
z value |
P value |
|
|
|
||||
|
Swollen joint count 14 to 20 |
0.27 |
0.53 |
0.52 |
0.60 |
|
Swollen joint count ≥ 20 |
1.25 |
0.68 |
1.84 |
0.06 |
|
CRP 4 to 35 mg/L |
0.83 |
0.57 |
1.45 |
0.15 |
|
CRP ≥ 35 mg/L |
0.86 |
0.63 |
1.36 |
0.17 |
|
ACPA status |
1.11 |
0.40 |
2.75 |
0.006 |
|
Typical RA erosion |
1.31 |
0.63 |
3.53 |
0.0004 |
|
Intercept |
-3.94 |
0.58 |
-6.74 |
1.62e-11 |
|
|
||||
|
ACPA, anti-citrullinated protein antibody; CRP, C-reactive protein; DMARD, disease-modifying anti-rheumatic drugs; RA, rheumatoid arthritis |
||||
|
Fautrel et al. Arthritis Research & Therapy 2012 14:R249 doi:10.1186/ar4092 |
||||